Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin ii-induced renal injury in sprague-dawley rats

Hypertension

Volumn 58, Issue 4, 2011, Pages 657-664

  Zhu, Qing ^a   Wang, Zhengchao ^a   Xia, Min ^a   Li, Pin Lan ^a   Van Tassell, Benjamin W ^b   Abbate, Antonio ^a   Dhaduk, Romesh ^a   Li, Ningjun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b School of Pharmacy   (United States)

Author keywords

albuminuria; fibrosis; glomerular sclerosis; renal blood flow; tubulointerstitial

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN; CREATININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SHORT HAIRPIN RNA; VASCULOTROPIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CREATININE CLEARANCE; DNA TRANSFECTION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; IN VIVO STUDY; KIDNEY BLOOD FLOW; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UPREGULATION;

ALBUMINURIA; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CHRONIC DISEASE; CREATININE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE SILENCING; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053564265     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.177626     Document Type: Article

References (70)

1. Nangaku M, Fujita T. Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertens Res. 2008;31:175-184. (Pubitemid 351461095)
2. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17: 17-25.
3. Higgins DF, Kimura K, Iwano M, Haase VH. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle. 2008;7: 1128-1132. (Pubitemid 351749261)
4. Haase VH. Pathophysiological Consequences of HIF Activation. Ann N Y Acad Sci. 2009;1177:57-65.
5. Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med. 2007;85:1325-1330. (Pubitemid 50004091)
6. Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int. 2008;74:867-872.
7. Norman JT, Orphanides C, Garcia P, Fine LG. Hypoxia-induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol. 1999;7: 463-469. (Pubitemid 29517356)
8. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 2000;58:2351-2366.
9. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007; 117:3810-3820. (Pubitemid 350224091)
10. Rosenberger C, Rosen S, Shina A, Frei U, Eckardt K-U, Flippin LA, Arend M, Klaus SJ, Heyman SN. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol Dial Transplant. 2008;23:3472-3478.
11. Hill P, Shukla D, Tran MGB, Aragones J, Cook HT, Carmeliet P, Maxwell PH. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 2008;19: 39-46.
12. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens. 2004;13:279-284. (Pubitemid 38582300)
13. Klahr S, Morrissey J. Progression of chronic renal disease. Am J Kidney Dis. 2003;41:S3-S7. (Pubitemid 36278335)
14. O'Donnell MP. Renal tubulointerstitial fibrosis: new thoughts on its development and progression. Postgrad Med. 2000;108:159-162, 165, 171-152.
15. Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, Kubo A, Akai Y, Rankin EB, Neilson EG, Haase VH, Saito Y. Stable expression of HIF-1αin tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol. 2008;295:F1023-F1029.
16. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant. 2006;21:16-20. (Pubitemid 43057101)
17. Chen X, Wang J, Zhou F, Wang X, Feng Z. STAT proteins mediate angiotensin II-induced production of TIMP-1 in human proximal tubular epithelial cells. Kidney Int. 2003;64:459-467. (Pubitemid 36871917)
18. Chen TH, Wang JF, Chan P, Lee HM. Angiotensin II stimulates hypoxiainducible factor 1αaccumulation in glomerular mesangial cells. Ann N Y Acad Sci. 2005;1042:286-293. (Pubitemid 40967650)
19. Sanchez-Lopez E, Lopez AF, Esteban V, Yague S, Egido J, Ruiz-Ortega M, MV. A-A. Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1αinduction and redox mechanisms in the kidney. Antiox Redox Signal. 2005;7:1275-1284. (Pubitemid 41232525)
20. Wang Z, Tang L, Zhu Q, Yi F, Zhang F, Li PL, Li N. Hypoxia-inducible factor-1αcontributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int. 2011;79:300-310.
21. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu H-J, Morishita R, Johnson RJ. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol. 2003;14:1535-1548. (Pubitemid 36687055)
22. Hou C-C, Wang W, Huang XR, Fu P, Chen T-H, Sheikh-Hamad D, Lan HY. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-{β} signaling and fibrosis in rat remnant kidney. Am J Pathol. 2005;166:761-771. (Pubitemid 40315633)
23. Ng Y-Y, Hou C-C, Wang W, Huang XR, Lan HY. Blockade of NF B activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int. 2005;67:s83-s91.
24. Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, Tachibana K, Ogihara T, Morishita R. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med. 2005;7:108-116.
25. Li N, Chen L, Yi F, Xia M, Li P-L. Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1αin the renal medulla. Circ Res. 2008;102:1101-1108. (Pubitemid 351667864)
26. Yi F, Xia M, Li N, Zhang C, Tang L, Li P-L. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension. 2009;53:90-96.
27. Li N, Yi F, dos Santos EA, Donley DK, Li P-L. Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure. Hypertension. 2007;49:148-154. (Pubitemid 46360354)
28. Goel M, Sinkins WG, Zuo C-D, Estacion M, Schilling WP. Identification and localization of TRPC channels in the rat kidney. Am J Physiol Renal Physiol. 2006;290:F1241-F1252. (Pubitemid 43724925)
29. Szczypka MS, Westover AJ, Clouthier SG, Ferrara JL, Humes HD. Rare incorporation of bone marrow-derived cells into kidney after folic acidinduced injury. Stem Cells. 2005;23:44-54. (Pubitemid 40105290)
30. Cook JS, Sauder CL, Ray CA. Melatonin differentially affects vascular blood flow in humans. Am J Physiol Heart Circ Physiol. 2011;300: H670-H674.
31. Dieterle F, Marrer E, Suzuki E, Grenet O, Cordier A, Vonderscher J. Monitoring kidney safety in drug development: emerging technologies and their implications. Curr Opin Drug Discov Devel. 2008;11:60-71.
32. Sullivan JC, Wang B, Boesen EI, D'Angelo G, Pollock JS, Pollock DM. Novel use of ultrasound to examine regional blood flow in the mouse kidney. Am J Physiol Renal Physiol. 2009;297:F228-F235.
33. Goldberg BB, McGahan JP. Atlas of Ultrasound Measurements. 2nd ed. Philadelphia, PA: Mosby Elsevier Health Sciences; 2006.
34. Li N, Yi F, Sundy CM, Chen L, Hilliker ML, Donley DK, Muldoon DB, Li PL. Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. Am J Physiol Renal Physiol. 2007;292:F207-F216. (Pubitemid 46105261)
35. Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol. 2006;177:4094-4102. (Pubitemid 44359944)
36. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26: 137-143. (Pubitemid 14017051)
37. Nangaku M, Yamada K, Gariepy CE, Miyata T, Inagi R, Kurokawa K, Yanagisawa M, Fujita T, Johnson RJ. ETB receptor protects the tubulointerstitium in experimental thrombotic microangiopathy. Kidney Int. 2002;62:922-928. (Pubitemid 35316721)
38. Mori T, Cowley AW Jr. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension. 2004;43:752-759. (Pubitemid 38405582)
39. Wolak T, Kim H, Ren Y, Kim J, Vaziri ND, Nicholas SB. Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int. 2009;76:32-43.
40. Evans RG, Eppel GA, Anderson WP, Denton KM. Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens. 2004;22:1439-1451. (Pubitemid 39037589)
41. Mattson DL. Importance of the renal medullary circulation in the control of sodium excretion and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2003;284:R13-R27. (Pubitemid 36008650)
42. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004; 65:2003-2017. (Pubitemid 38669987)
43. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol. 2007;106:26-31.
44. Kang YS, Park YG, Kim BK, Han SY, Jee YH, Han KH, Lee MH, Song HK, Cha DR, Kang SW, Han DS. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol. 2006;36:377-388.
45. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-βand VEGF signalling: implications for diabetic glomerulopathy. Nephrol Dial Transplant. 2005;20:1320-1328. (Pubitemid 41430605)
46. Ziyadeh FN. Different roles for TGF-βand VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Diabetes Res Clin Pract. 2008;82(suppl 1):S38-S41.
47. Ruster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006;17:2985-2991. (Pubitemid 44707758)
48. Suga S, Mazzali M, Ray PE, Kang DH, Johnson RJ. Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency. Kidney Int. 2002;61:951-958. (Pubitemid 34175463)
49. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens. 2003;12:25-29. (Pubitemid 36092311)
50. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 1999;56:1627-1637. (Pubitemid 29518163)
51. Wolf G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-βpathway. Kidney Int. 2006; 70:1914-1919. (Pubitemid 44863378)
52. Luo Y, He DL, Ning L, Shen SL, Li L, Li X. Hypoxia-inducible factor-1αinduces the epithelial-mesenchymal transition of human prostatecancer cells. Chin Med J (Engl). 2006;119:713-718. (Pubitemid 43796824)
53. Carvajal G, Rodriguez-Vita J, Rodrigues-Diez R, Sanchez-Lopez E, Ruperez M, Cartier C, Esteban V, Ortiz A, Egido J, Mezzano SA, Ruiz-Ortega M. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int. 2008;74:585-595.
54. Mori T, Polichnowski A, Glocka P, Kaldunski M, Ohsaki Y, Liang M, Cowley AW Jr. High perfusion pressure accelerates renal injury in saltsensitive hypertension. J Am Soc Nephrol. 2008;19:1472-1482.
55. Xia M, Li PL, Li N. Telemetric signal-driven servocontrol of renal perfusion pressure in acute and chronic rat experiments. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1494-R1501.
56. Fujimoto S, Satoh M, Nagasu H, Horike H, Sasaki T, Kashihara N. Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats. Nephrol Dial Transplant. 2009;24:3651-3658.
57. Thomas MC, Tikellis C, Burns WM, Bialkowski K, Cao Z, Coughlan MT, Jandeleit-Dahm K, Cooper ME, Forbes JM. Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol. 2005;16:2976-2984. (Pubitemid 44743495)
58. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr. HIFαtargeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464-468. (Pubitemid 32335941)
59. Jaakkola P, Mole DR, Tian Y-M, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim Av, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-αto the Von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468-472. (Pubitemid 32335942)
60. Callapina M, Zhou J, Schnitzer S, Metzen E, Lohr C, Deitmer JW, Brune B. Nitric oxide reverses desferrioxamine-and hypoxia-evoked HIF- 1αaccumulation: implications for prolyl hydroxylase activity and iron. Exp Cell Res. 2005;306:274-284. (Pubitemid 40692790)
61. Page EL, Chan DA, Giaccia AJ, Levine M, Richard DE. Hypoxia-inducible factor-1αstabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell. 2008;19:86-94. (Pubitemid 351186135)
62. McMahon S, Charbonneau M, Grandmont S, Richard DE, Dubois CM. Transforming growth factorβ1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem. 2006;281:24171-24181. (Pubitemid 44274191)
63. Tug S, Reyes BD, Fandrey J, Berchner-Pfannschmidt U. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors. Biochem Biophys Res Commun. 2009;384:519-523.
64. Tanaka T, Matsumoto M, Inagi R, Miyata T, Kojima I, Ohse T, Fujita T, Nangaku M. Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis. Kidney Int. 2005; 68:2714-2725. (Pubitemid 43251016)
65. Ohtomo S, Nangaku M, Izuhara Y, Takizawa S, Strihou CvYd, Miyata T. Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrol Dial Transplant. 2008;23:1166-1172. (Pubitemid 351767476)
66. Song YR, You SJ, Lee YM, Chin HJ, Chae DW, Oh YK, Joo KW, Han JS, Na KY. Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transplant. 2010;25:77-85.
67. Tanaka T, Kojima I, Ohse T, Ingelfinger JR, Adler S, Fujita T, Nangaku M. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest. 2005;85:1292-1307. (Pubitemid 41348643)
68. Guo M, Song LP, Jiang Y, Liu W, Yu Y, Chen GQ. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1αindependent mechanisms. Apoptosis. 2006;11:67-77. (Pubitemid 43151645)
69. Davidson T, Salnikow K, Costa M. Hypoxia inducible factor-1α- independent suppression of aryl hydrocarbon receptor-regulated genes by nickel. Mol Pharmacol. 2003;64:1485-1493. (Pubitemid 37540394)
70. Kivirikko KI, Myllyharju J. Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 1998;16:357-368. (Pubitemid 28069862)